Leonard Schleifer
#1658

Leonard Schleifer

United States 74 years old Self-Made

Overview

Source of Wealth
Pharmaceuticals
Industry
Healthcare
Residence
Tarrytown, New York
Organization
CEO and Founder at Regeneron Pharmaceuticals
Education
Cornell University (Bachelor of Arts/Science)
University of Virginia (Medical Doctor)
University of Virginia (Ph.D)
Marital Status
Married
Children
3

Assets

  • Regeneron Pharmaceuticals
    2,413,546 shares @ -
    -
    REGN-US
  • Regeneron Pharmaceuticals
    139,474 shares @ -
    -
    REGN-US
  • Regeneron Pharmaceuticals
    129,013 shares @ -
    -
    REGN-US
  • Regeneron Pharmaceuticals
    81,278 shares @ -
    -
    REGN-US
  • Regeneron Pharmaceuticals
    146,815 shares @ -
    -
    REGN-US

Biography

Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York-based company.

Schleifer took Regeneron public in 1991; he owns 2% of the company's common stock.

Sales of Regeneron's blockbuster drug Eylea, a treatment for macular degeneration, were $4.8 billion in the U.S. in 2024.

Regeneron has developed 12 FDA-approved medicines.

About

Schleifer attended Cornell on scholarship and dreamed of a medical career.

The son of a sweater manufacturer, Schleifer grew up in Queens, New York.